These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 29150151)
1. Evaluating short- and long-term impacts of a Medicaid "lock-in" program on opioid and benzodiazepine prescriptions dispensed to beneficiaries. Naumann RB; Marshall SW; Lund JL; Gottfredson NC; Ringwalt CL; Skinner AC Drug Alcohol Depend; 2018 Jan; 182():112-119. PubMed ID: 29150151 [TBL] [Abstract][Full Text] [Related]
2. Trajectories of dispensed prescription opioids among beneficiaries enrolled in a Medicaid controlled substance "lock-in" program. Naumann RB; Marshall SW; Gottfredson NC; Lund JL; Ringwalt CL; Skinner AC Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):16-24. PubMed ID: 29700904 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of a Medicaid Lock-in Program: Increased Use of Opioid Use Disorder Treatment but No Impact on Opioid Overdose Risk. Naumann RB; Roberts AW; Marshall SW; Skinner AC Med Care; 2019 Mar; 57(3):213-217. PubMed ID: 30629016 [TBL] [Abstract][Full Text] [Related]
5. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States. Moyo P; Simoni-Wastila L; Griffin BA; Onukwugha E; Harrington D; Alexander GC; Palumbo F Addiction; 2017 Oct; 112(10):1784-1796. PubMed ID: 28498498 [TBL] [Abstract][Full Text] [Related]
6. A comparison of trends in opioid dispensing patterns between Medicaid pharmacy claims and prescription drug monitoring program data. El Ibrahimi S; Hallvik S; Johnston K; Leichtling G; Choo E; Hartung DM Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1168-1174. PubMed ID: 32939909 [TBL] [Abstract][Full Text] [Related]
7. The lock-in loophole: Using mixed methods to explain patient circumvention of a Medicaid opioid restriction program. Roberts AW; Skinner AC; Lauffenburger JC; Galt KA Subst Abus; 2020; 41(4):510-518. PubMed ID: 31644398 [TBL] [Abstract][Full Text] [Related]
8. Controlled Substance Lock-In Programs: Examining An Unintended Consequence Of A Prescription Drug Abuse Policy. Roberts AW; Farley JF; Holmes GM; Oramasionwu CU; Ringwalt C; Sleath B; Skinner AC Health Aff (Millwood); 2016 Oct; 35(10):1884-1892. PubMed ID: 27702963 [TBL] [Abstract][Full Text] [Related]
9. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines. Manders L; Abd-Elsayed A Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396 [TBL] [Abstract][Full Text] [Related]
10. Using prescription monitoring program data to characterize out-of-pocket payments for opioid prescriptions in a state Medicaid program. Hartung DM; Ahmed SM; Middleton L; Van Otterloo J; Zhang K; Keast S; Kim H; Johnston K; Deyo RA Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1053-1060. PubMed ID: 28722211 [TBL] [Abstract][Full Text] [Related]
11. Impacts of a Medicaid "lock-in" program on opioid use disorder treatment and services and naloxone dispensing. Naumann RB; Austin AE; Wang L; Roberts AW Drug Alcohol Depend; 2022 Apr; 233():109385. PubMed ID: 35276627 [TBL] [Abstract][Full Text] [Related]
12. Prescription drug monitoring and dispensing of prescription opioids. Brady JE; Wunsch H; DiMaggio C; Lang BH; Giglio J; Li G Public Health Rep; 2014; 129(2):139-47. PubMed ID: 24587548 [TBL] [Abstract][Full Text] [Related]
13. Health Care Utilization and Comorbidity History of North Carolina Medicaid Beneficiaries in a Controlled Substance "Lock-in" Program. Naumann RB; Marshall SW; Lund JL; Skinner AC; Ringwalt C; Gottfredson NC N C Med J; 2019; 80(3):135-142. PubMed ID: 31072939 [No Abstract] [Full Text] [Related]
15. Estimating the Direct Costs of Outpatient Opioid Prescriptions: A Retrospective Analysis of Data from the Rhode Island Prescription Drug Monitoring Program. Aroke H; Buchanan A; Wen X; Ragosta P; Koziol J; Kogut S J Manag Care Spec Pharm; 2018 Mar; 24(3):214-224. PubMed ID: 29485950 [TBL] [Abstract][Full Text] [Related]
16. Risk Factors and Outcomes of Opioid Users with and Without Concurrent Benzodiazepine Use in the North Carolina Medicaid Population. Hung A; Bush C; Greiner M; Campbell H; Hammill B; Maciejewski ML; McKethan A J Manag Care Spec Pharm; 2020 Feb; 26(2):169-175. PubMed ID: 32011957 [TBL] [Abstract][Full Text] [Related]
17. Racial disparities across provider specialties in opioid prescriptions dispensed to medicaid beneficiaries with chronic noncancer pain. Ringwalt C; Roberts AW; Gugelmann H; Skinner AC Pain Med; 2015 Apr; 16(4):633-40. PubMed ID: 25287703 [TBL] [Abstract][Full Text] [Related]
18. Assessing the present state and potential of Medicaid controlled substance lock-in programs. Roberts AW; Skinner AC J Manag Care Spec Pharm; 2014 May; 20(5):439-46c. PubMed ID: 24761815 [TBL] [Abstract][Full Text] [Related]